Filing Details

Accession Number:
0001165527-10-000600
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-08-18 13:00:00
Reporting Period:
2010-07-15
Filing Date:
2010-08-18
Accepted Time:
2010-08-18 18:46:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1424860 Enox Biopharma Inc N/A Surgical & Medical Instruments & Apparatus (3841) 260477124
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1454396 Itamar David 13 Ahuza St.
Pardes Hana L3 37075
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-07-15 201,122 $0.30 500,483 No 4 P Direct
Common Stock Acquisiton 2010-08-12 25,000 $2.00 525,483 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Commom Stock Warrant Acquisiton 2010-08-12 12,500 $0.00 12,500 $4.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,500 2010-08-12 2012-08-12 No 4 P Direct
Footnotes
  1. Reporting Person disclaims beneficial ownership of shares owned by his spouse, Hadas David.
  2. Purchase agreement includes a one year adjusting pre-emption provision to increase number of shares of holder upon payment of par value, at Reporting Person's election if Company sells shares at less than purchase price.
  3. Exercise price subject to downward formula adjustment if Company sells or commits to sell shares at less than $2.00 during the one year after issuance of Warrant.
  4. Exercise period subject to extension equal to expiration date of any different class of warrants sold by company during the one year after issuance of Warrant.